NIH updates clinical trial definition to exclude basic experimental studies involving humans from clinical trial requirements starting May 2026.

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease marked by irreversible fibrosis and poor prognosis. Growing disease awareness and improved diagnostics are expanding the ...

Scientific advancements have helped millions of people living with cancer, heart disease, arthritis, obesity, and other diseases. Essential for the development of new therapies are the thousands of ...

In paediatrics, “more trials have been done over the last ten years, but we have struggled with transparency and clarity, and sometimes with the quality because they are not always asking the ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate them.

Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from ...

A comprehensive search was conducted in PubMed, Web of Science, and OpenAlex for literature published between December 1, 2022, and December 31, 2024. Studies were included if they explicitly ...

The DAPA ECHO trial focused on dapagliflozin's effects on myocardial performance in nondiabetic heart failure patients. A randomized, double-blind, placebo-controlled design was employed, using ...